Dr. Hönle Toekomstige groei
Future criteriumcontroles 4/6
Dr. Hönle is forecast to grow earnings and revenue by 120.7% and 8.4% per annum respectively. EPS is expected to grow by 120.6% per annum. Return on equity is forecast to be 5.2% in 3 years.
Belangrijke informatie
120.7%
Groei van de winst
120.6%
Groei van de winst per aandeel
| Electrical winstgroei | 29.6% |
| Inkomstengroei | 8.4% |
| Toekomstig rendement op eigen vermogen | 5.2% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 20 Aug 2024 |
Recente toekomstige groei-updates
Recent updates
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%
Sep 26
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S
Aug 06Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?
Jul 02Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear
Feb 08We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt
Oct 11Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Aug 07Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 03The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence
Nov 03Dr. Hönle (ETR:HNL) Has No Shortage Of Debt
Sep 29There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital
Jul 06Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal
Feb 20Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 15Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 14Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?
May 30Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital
May 17Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)
Mar 29Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?
Mar 16We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt
Mar 03Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Feb 20
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide
Feb 08Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?
Jan 25Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?
Jan 11What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?
Dec 27Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 15Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?
Dec 03These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively
Nov 22Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 9/30/2027 | 132 | N/A | N/A | N/A | 1 |
| 9/30/2026 | 121 | 6 | 5 | 12 | 2 |
| 9/30/2025 | 110 | 3 | 1 | 7 | 2 |
| 9/30/2024 | 98 | -1 | 4 | 9 | 2 |
| 6/30/2024 | 99 | -5 | 2 | 5 | N/A |
| 3/31/2024 | 101 | -14 | 3 | 5 | N/A |
| 12/31/2023 | 103 | -14 | 0 | 2 | N/A |
| 9/30/2023 | 106 | -11 | 0 | 3 | N/A |
| 6/30/2023 | 109 | -10 | -3 | -2 | N/A |
| 3/31/2023 | 109 | -1 | -2 | 0 | N/A |
| 12/31/2022 | 113 | 1 | -3 | 2 | N/A |
| 9/30/2022 | 116 | 3 | -12 | -7 | N/A |
| 6/30/2022 | 118 | -3 | -16 | -5 | N/A |
| 3/31/2022 | 118 | -3 | -17 | -4 | N/A |
| 12/31/2021 | 119 | -3 | -20 | -6 | N/A |
| 9/30/2021 | 115 | -5 | -16 | 1 | N/A |
| 6/30/2021 | 107 | 6 | -14 | 5 | N/A |
| 3/31/2021 | 101 | 6 | -20 | 4 | N/A |
| 12/31/2020 | 95 | 5 | -21 | 6 | N/A |
| 9/30/2020 | 94 | 6 | -23 | 7 | N/A |
| 6/30/2020 | 98 | 8 | -23 | 11 | N/A |
| 3/31/2020 | 103 | 10 | -18 | 13 | N/A |
| 12/31/2019 | 103 | 10 | -11 | 13 | N/A |
| 9/30/2019 | 108 | 12 | -2 | 17 | N/A |
| 6/30/2019 | 119 | 17 | 1 | 16 | N/A |
| 3/31/2019 | 122 | 18 | 5 | 18 | N/A |
| 12/31/2018 | 127 | 21 | 16 | 27 | N/A |
| 9/30/2018 | 127 | 22 | 14 | 24 | N/A |
| 6/30/2018 | 119 | 19 | 18 | 22 | N/A |
| 3/31/2018 | 116 | 17 | N/A | 18 | N/A |
| 12/31/2017 | 110 | 14 | N/A | 8 | N/A |
| 9/30/2017 | 102 | 10 | N/A | 7 | N/A |
| 6/30/2017 | 97 | 8 | N/A | 5 | N/A |
| 3/31/2017 | 96 | 9 | N/A | 8 | N/A |
| 12/31/2016 | 93 | 8 | N/A | 8 | N/A |
| 9/30/2016 | 94 | 8 | N/A | 9 | N/A |
| 6/30/2016 | 94 | 9 | N/A | 11 | N/A |
| 3/31/2016 | 93 | 9 | N/A | 10 | N/A |
| 12/31/2015 | 93 | 10 | N/A | 12 | N/A |
| 9/30/2015 | 93 | 10 | N/A | 9 | N/A |
| 6/30/2015 | 88 | 8 | N/A | 7 | N/A |
| 3/31/2015 | 86 | 8 | N/A | 6 | N/A |
| 12/31/2014 | 84 | 6 | N/A | 5 | N/A |
| 9/30/2014 | 82 | 6 | N/A | 7 | N/A |
| 6/30/2014 | 80 | 8 | N/A | 7 | N/A |
| 3/31/2014 | 82 | 7 | N/A | 7 | N/A |
| 12/31/2013 | 81 | 7 | N/A | 5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: HNL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Winst versus markt: HNL is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hoge groeiwinsten: HNL is expected to become profitable in the next 3 years.
Omzet versus markt: HNL's revenue (8.4% per year) is forecast to grow faster than the German market (5.5% per year).
Hoge groei-inkomsten: HNL's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: HNL's Return on Equity is forecast to be low in 3 years time (5.2%).